Target Price | $3.40 |
Price | $4.00 |
Deviation |
15.00%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Agilon Health Inc 2026 .
The average Agilon Health Inc target price is $3.40.
This is
15.00%
register free of charge
$6.00
50.00%
register free of charge
$2.00
50.00%
register free of charge
|
|
A rating was issued by 21 analysts: 2 Analysts recommend Agilon Health Inc to buy, 17 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Agilon Health Inc stock has an average upside potential 2026 of
15.00%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 6.06 | 6.02 |
40.41% | 0.67% | |
EBITDA Margin | -4.28% | -1.30% |
12.73% | 69.64% | |
Net Margin | -4.15% | -2.50% |
18.03% | 39.74% |
19 Analysts have issued a sales forecast Agilon Health Inc 2025 . The average Agilon Health Inc sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Agilon Health Inc EBITDA forecast 2025. The average Agilon Health Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Agilon Health Inc Analysts have issued a net profit forecast 2025. The average Agilon Health Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.61 | -0.37 |
15.09% | 39.34% | |
P/E | negative | |
EV/Sales | 0.21 |
7 Analysts have issued a Agilon Health Inc forecast for earnings per share. The average Agilon Health Inc EPS is
This results in the following potential growth metrics and future valuations:
Agilon Health Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Needham |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Bernstein |
Locked
➜
Locked
|
Locked | Jan 15 2025 |
Needham |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Analyst Rating | Date |
---|---|
Locked
Needham:
Locked
➜
Locked
|
Mar 21 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Bernstein:
Locked
➜
Locked
|
Jan 15 2025 |
Locked
Needham:
Locked
➜
Locked
|
Jan 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.